March 12, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 62 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: US 8106242
Title: Process for the preparation of compounds via hazardous intermediates in a series of microreactors.
Inventor(s): Reintjens, Rafael Wilhelmus Elisabeth Ghislain; Broxterman, Quirinus Bernardus; Kotthaus, Martina; Poechlauer, Peter
Patent Assignee(s): DSM IP Assets B.V., Neth.
Source: PCT Int. Appl., 22 pp. CODEN: PIXXD2
Language: English

Abstract:
A multistep process for the preparation of compds. via hazardous intermediates comprises (a) preparing in a microreactor a hazardous intermediate, (b) optionally performing one or more reaction steps on the hazardous intermediate in one or more addnl. microreactors, and (c) further converting the hazardous intermediate with a suitable reaction agent in a subsequent microreactor until a stable end product is formed.  Thus, aqueous NaN3 and 3-phenylpropanol mesylate in NMP were added to a mini tube reactor at 111-113 degree to give 95% conversion to 3-phenylpropyl azide after 60 min.  The product solution was diluted with addnl. NMP and added along with H2 to a capillary reactor having a fused silica wall coated with alumina and Pd crystallites at 26 degree to give 3-phenyl-1-propylamine with 100% selectivity and 48% conversion.

Please note:  Abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. CAS enhanced the abstract using additional information found in the patent.

 

View the full-text U.S. patent from USPTO.

Recent News


    August 7, 2015 | CAS Announces the 2015 SciFinder
    Future Leaders in Chemistry and First-Ever Alumni
    Program
   
    August 3, 2015 | New STN Breaks Ground with
    Markush Structure Search and Enhanced Content
    for Intellectual Property Exploration and Research
   
    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org